Data / Drug companies / Vigabatrin
Vigabatrin: 18 companies and 24 products in the FDA NDC directory
Vigabatrin is listed in the FDA National Drug Code Directory by 18 companies, with 24 products in commercial distribution. 21 of the products (87.5%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are powder, for solution; tablet, film coated; tablet, and the newest product started marketing on February 18, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 18
- Products
- 24
- Generic (ANDA) products
- 21 (87.5%)
- Application numbers
- 21
- Routes
- Oral
- Brand names
- Sabril, Vigadrone, Vigafyde
- openFDA record search
- api.fda.gov
Companies that list vigabatrin
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Aurobindo Pharma Limited | 2 | powder, for solution; tablet | Generic drugs (ANDA) | May 10, 2022 |
| Dr. Reddy's Laboratories Inc. | 2 | tablet, film coated; powder, for solution | Generic drugs (ANDA) | February 1, 2021 |
| Lundbeck Pharmaceuticals LLC | 2 | tablet, film coated; powder, for solution | New drug applications (NDA) | August 21, 2009 |
| Upsher-Smith Laboratories, LLC | 2 | powder, for solution; tablet | Generic drugs (ANDA) | June 29, 2023 |
| Zydus Lifesciences Limited | 2 | powder, for solution; tablet, film coated | Generic drugs (ANDA) | March 24, 2025 |
| Zydus Pharmaceuticals USA Inc. | 2 | tablet, film coated; powder, for solution | Generic drugs (ANDA) | March 24, 2025 |
| Actavis Pharma, Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | February 6, 2019 |
| Amneal Pharmaceuticals NY LLC | 1 | for solution | Generic drugs (ANDA) | December 7, 2023 |
| Amneal Pharmaceuticals NY LLC | 1 | for solution | Generic drugs (ANDA) | March 19, 2018 |
| Ascend Laboratories, LLC | 1 | powder, for solution | Generic drugs (ANDA) | December 3, 2020 |
| Camber Pharmaceuticals, Inc. | 1 | powder, for solution | Generic drugs (ANDA) | January 26, 2021 |
| Carnegie Pharmaceuticals LLC | 1 | tablet, film coated | Generic drugs (ANDA) | February 18, 2026 |
| Cipla USA Inc. | 1 | powder, for solution | Generic drugs (ANDA) | December 4, 2019 |
| Edenbridge Pharmaceuticals LLC. | 1 | tablet | Generic drugs (ANDA) | June 29, 2022 |
| Hikma Pharmaceuticals USA Inc. | 1 | tablet | Generic drugs (ANDA) | September 9, 2022 |
| Novadoz Pharmaceuticals LLC | 1 | for solution | Generic drugs (ANDA) | September 7, 2022 |
| Par Health USA, LLC | 1 | powder, for solution | Generic drugs (ANDA) | April 27, 2017 |
| Upsher-Smith Laboratories, LLC | 1 | solution | New drug applications (NDA) | June 18, 2024 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder, for solution | 10 | 41.7% |
| Tablet, film coated | 6 | 25% |
| Tablet | 4 | 16.7% |
| For solution | 3 | 12.5% |
| Solution | 1 | 4.2% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 21 | 87.5% |
| New drug applications (NDA) | 3 | 12.5% |
Pharmacologic classes
| Class | Products |
|---|---|
| Anti-epileptic Agent | 24 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.